CD63 and Miyoshi myopathy: O’Sullivan et al.’s study showed that compared to the healthy control group, the levels of P-selectin and CD63 were significantly elevated at the time of MM diagnosis and remained high after treatment; however, both pre- and post-treatment, the patient response to agonists showed significant decreases in PAC-1 binding and P-selectin levels [30].